Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
NF-B
100%
Natural Killer Cells
100%
Receptor 2
100%
Toll-like
100%
Myeloid Differentiation Factor 88 (MyD88)
100%
Extracellular Vesicles
100%
Lupus Nephritis
100%
Streptococcus Anginosus
100%
Systemic Lupus Erythematosus
33%
NK Cell Activity
25%
Healthy Controls
16%
Inflammatory Cytokines
16%
Systemic Lupus Erythematosus Patient
16%
SLE Disease Activity Index (SLEDAI)
16%
Lpr Mice
16%
Inflammatory Response
8%
Quantitative PCR
8%
Blood Samples
8%
Cytotoxicity
8%
Prolonged Survival
8%
Signaling Pathway
8%
Systemic Inflammation
8%
Therapeutic Intervention
8%
Fecal Samples
8%
Flow Cytometry
8%
Stool
8%
Disease Pathogenesis
8%
Inflammatory Mediators
8%
Index Score
8%
Cell Depletion
8%
Serum Samples
8%
Inhibitory Receptors
8%
Cytokine Profile
8%
Histopathological Changes
8%
NK Cell Cytotoxicity
8%
Patient Relatives
8%
Orally Administered
8%
Cytokine Levels
8%
Activation Markers
8%
Lupus
8%
NKG2A
8%
Granzyme B
8%
Immune Infiltration
8%
NKp44
8%
Lipoteichoic Acid
8%
NKp46
8%
Overabundance
8%
Gut Dysbiosis
8%
Microbial Imbalance
8%
NK1.1
8%
TIGIT
8%
Tim-3
8%
Immune Complex Deposition
8%
SLEDA
8%
Hyperactivating
8%
Streptococcus Salivarius
8%
Immunology and Microbiology
TLR2
100%
Natural Killer Cell
100%
Nephritis
100%
Streptococcus anginosus
100%
Lupus Erythematosus
100%
Systemic Lupus Erythematosus
88%
Cell Activation
33%
Cytotoxicity
22%
Murphy Roths Large Lymphoproliferative Mouse
22%
Tumor Necrosis Factor
11%
Inflammation Response
11%
Inflammatory Cytokine
11%
Signal Transduction
11%
Systemic Inflammation
11%
Proinflammatory Cytokine
11%
Real-Time Polymerase Chain Reaction
11%
Mediator
11%
ELISA
11%
Occult Blood
11%
Gut Microbiome
11%
Lipoteichoic Acid
11%
Immune Cell Infiltration
11%
Granzyme B
11%
Immune Complex Deposition
11%
Dysbiosis
11%
In Vitro
11%
INIS
receptors
100%
streptococcus
100%
nk cells
100%
nephritis
100%
lupus
100%
kidneys
33%
diseases
25%
patients
25%
control
25%
mice
25%
inflammation
25%
levels
16%
toxicity
16%
cytokines
16%
antibodies
8%
comparative evaluations
8%
blood
8%
stimulation
8%
pathology
8%
interventions
8%
production
8%
pathogenesis
8%
in vivo
8%
pcr
8%
in vitro
8%
abundance
8%
deposition
8%
elisa
8%